Clinical Study

MaquiBright™ – the paradigm shattering treatment for dry eye symptoms has arrived.

Format: PDF file | Document type: Clinical Study | Promoted Content

This Clinical Study has been written by Maqui New Life AG , and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

MaquiBright™ the oral supplement solution for dry eyes symptoms increases tear production by 47.6% after 30 days

Eye Aging, oxidative stress and inflammation affect the functionality of tear-fluid generating lachrymal glands and certain professions contribute to the development of dry eyes. Your customers are looking for a lasting health restoration. 

Clinical investigations with MaquiBright™ demonstrate restoration of tear-fluid production from tear glands and a reduction of dry eye-related symptoms

Related resources from Maqui New Life AG

Supplier info centre